首頁 > 市場調查報告書 > 醫療設備

藥物遞輸設備呼吸器

市場調查報告書

商品編碼

1471975

霧化器市場規模和預測、全球和區域佔有率、趨勢和成長機會分析報告範圍：按類型、應用、最終用戶和地理位置

Nebulizers Market Size and Forecast, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type, Application, End User, and Geography

出版日期: 2024年03月12日 | 出版商:

The Insight Partners | 英文 150 Pages | 商品交期: 1-5個工作天內

價格

簡介目錄

2023年霧化器市場價值為81,588萬美元，預計到2031年將達到131,557萬美元；預計 2023-2031 年複合年成長率為 6.2%。

推動市場成長的關鍵因素是慢性呼吸道疾病盛行率的上升以及家庭護理環境對呼吸設備的需求不斷增加正在推動市場的成長。然而，缺乏早期診斷和霧化治療的高成本阻礙了霧化器市場的成長。

霧化器市場的市場趨勢

霧化器技術的變化是由臨床需求和新藥理製劑的開發所推動的，這需要特殊的技術和性能特徵。由於最佳化新藥物輸送的強大經濟壓力，創新輸送設備（例如用於霧化治療的跨黏膜藥物輸送系統）的開發規模已擴大。隨著新的醫學知識和有效的藥物的出現，各種霧化器的治療不斷取得進展。霧化器技術的這些進步催生了使用微泵技術產生氣霧劑的網狀霧化器。除了霧化器的眾多優點之外，越來越多的產品批准和開發可能會增強未來幾年的需求。根據公司新聞稿，以下列出了一些主要的開發和批准：

2021 年 7 月，HCmed Innovations 的普莫金振動網狀霧化器獲得美國食品藥物管理局 (FDA) 批准。它採用HCmed的先進技術，將液體藥物轉化為微小的氣霧顆粒，可以直接輸送到呼吸道，緩解呼吸道疾病的不適。此外，該設備攜帶且易於使用，使其成為需要吸入治療的患者的便捷解決方案。

2020 年 6 月，Respira Technologies, Inc. 推出了 RespiRx 藥物輸送設備平台。這個新穎的平台是一款超攜帶式手持式振動網霧化器 (VMN)，用於各種適應症的局部和全身治療，包括氣喘和慢性阻塞性肺病。 RespiRx 提供預先填充藥筒，其中包含一次性壓電元件和懸浮在水溶液中的藥物化合物。這種格式是為了方便患者而設計的，消除了由於清潔不當而導致的錯誤和誤用。該藥筒可進行編程以提供精確的劑量，並配備藍牙技術來追蹤劑量輸送、測量資料並為醫療保健提供者收集電子醫療記錄。

因此，各種市場參與者的技術進步和產品批准預計將在未來幾年帶來新的霧化器市場趨勢。

霧化器市場：細分概述

霧化器市場根據類型、應用和最終用戶進行細分。

按類型分類，市場分為噴射霧化器、超音波霧化器和網狀霧化器。噴射霧化器細分市場在2022 年佔據最大的市場佔有率。，以氣霧劑的形式輸送藥物。它們專為一次性使用而設計，無需滅菌並降低污染風險。噴射霧化器常用於機械通氣過程。這些霧化器在 CRD 治療中的各種應用正在推動預測期內噴射霧化器的市場規模。

根據應用，市場分為慢性阻塞性肺病、氣喘、囊性纖維化等。預計到2023 年，慢性阻塞性肺病(COPD) 細分市場將佔據最大的霧化器市場。 (COPD) 患者罹患心臟病、肺癌和各種其他疾病的風險增加狀況。據世界衛生組織 (WHO) 稱，慢性阻塞性肺病是全球第三大死因。隨著呼吸系統疾病負擔的增加，對吸入療法的需求也增加。此外，人們對居家照護治療偏好的轉變推動了手持式霧化器在慢性阻塞性肺病和氣喘治療中的應用。

根據最終用戶，霧化器市場分為醫院和診所、急診中心和家庭護理機構。醫院和診所細分市場在 2023 年佔據最大市場佔有率，由於各種類型霧化器的醫療可用性以及這些設備在醫院環境中的採用率不斷成長，預計 2023 年至 2030 年複合年成長率最高。

霧化器市場：地理概況

全球霧化器市場報告的範圍涵蓋北美（美國、加拿大和墨西哥）、歐洲（德國、法國、義大利、英國、西班牙和歐洲其他地區）、亞太地區（中國、日本、印度、澳洲、韓國和亞太其他地區）、中東和非洲（南非、沙烏地阿拉伯、阿拉伯聯合大公國以及中東和非洲其他地區）以及南美洲和中美洲（巴西、阿根廷和南美洲和中美洲其他地區）。 2023年，北美佔據主要霧化器市場佔有率，其次是歐洲；亞太地區的市場在預測期內以最高的複合年成長率成長。這歸因於新興市場醫療保健基礎設施的發展、醫療保健支出的增加、利潤豐厚的報銷政策以及該地區越來越重視更好的患者治療結果。

歐洲
- 德國
- 法國
- 義大利
- 西班牙
- 英國
- 歐洲其他地區
亞太
- 澳洲
- 中國
- 印度
- 日本
- 韓國
- 亞太其他地區
中東和非洲
- 南非
- 沙烏地阿拉伯
- 阿拉伯聯合大公國
- 中東和非洲其他地區
南美洲和中美洲
- 巴西
- 阿根廷
- 南美洲和中美洲其他地區

第 11 章：產業格局

併購
協議、合作、合資企業
新產品發布
擴張和其他策略發展

第 12 章：競爭格局

關鍵參與者的熱圖分析
公司定位與專注

第 13 章：霧化器市場 - 主要公司概況

GE Healthcare
Agilent Technologies, Inc.
Koninklijke Philips N.V.
Drive DeVilbiss International
Omron Healthcare, Inc.
Vectura Group Ltd
PARI Medical Holding GmbH
Trudell Medical International
Terumo Corporation
GF Health Products

第 14 章：附錄

簡介目錄

Product Code: TIPTE100001066

The nebulizers market was valued at US$ 815.88 million in 2023 and is expected to reach US$ 1315.57 million by 2031; it is estimated to record a CAGR of 6.2% during 2023-2031.

Key factors driving the market growth are the rising prevalence of chronic respiratory diseases and increasing demand for respiratory devices for home care settings are driving the growth of the market. However, the lack of early diagnosis and the high cost of nebulizing therapy hinder the nebulizers market growth.

Market Trends of the Nebulizers Market

Changes in nebulizer technology are driven by clinical needs and the development of new pharmacological agents, which require special techniques and performance characteristics. Due to strong economic pressures to optimize the delivery of newer medications, the development of innovative delivery devices, such as transmucosal drug delivery systems for nebulization therapies, has upscaled. With new medical knowledge and effective medicines, treatment with a wide range of nebulizers continues to advance. These advancements in nebulizer technology have led to the creation of mesh nebulizers that use micropump technology to produce aerosols. In addition to the numerous advantages of nebulizers, the growing number of product approvals and developments will likely strengthen the demand in the coming years. As per company press releases, a few major developments and approvals are listed below:

In July 2021, HCmed Innovations received US Food and Drug Administration (FDA) approval for Pulmogine Vibrating Mesh Nebulizer. It uses HCmed's advanced technology to convert liquid medication into tiny aerosol particles that can be directly delivered to the airways, relieving respiratory disease discomfort. Additionally, the device is portable and easy to use, making it a convenient solution for patients who require inhalation treatment.

In June 2020, Respira Technologies, Inc. launched its RespiRx drug delivery device platform. This novel platform is an ultra-portable handheld vibrating mesh nebulizer (VMN) for local and systemic treatment for various indications, including asthma and COPD. RespiRx offers a pre-filled cartridge that contains a disposable piezo element and the drug compound suspended in an aqueous solution. This format is designed for patients' convenience, eliminating errors and misuse due to improper cleaning. The cartridge is programmable to deliver precise doses and comes equipped with Bluetooth technology to track dose delivery, measure data, and collect electronic medical records for healthcare providers.

Therefore, such technological advancements by various market players and product approvals are anticipated to bring new nebulizers market trends in the coming years.

Nebulizers Market: Segmental Overview

The nebulizers market is segmented on the basis of type, application, and end- user.

By type, the market is segmented into jet nebulizers, ultrasonic nebulizers, and mesh nebulizers. The jet nebulizers segment held the largest market share in 2022. The Mesh Nebulizers segment is projected to register the highest CAGR from 2023 to 2031. Jet nebulizers are affordable and easy-to-use devices that deliver medication in the form of aerosol. They are designed for one-time use, eliminating the need for sterilization and reducing contamination risk. Jet nebulizers are commonly used during mechanical ventilation. The various application of these nebulizers in treatment of CRD is propelling the jet nebulizers market size during the forecast period.

The market, by application, is segmented into COPD, asthma, cystic fibrosis, and others. The COPD segment is anticipated to hold the largest nebulizers market share in 2023. The asthma segment is projected to grow with the highest CAGR from 2023 to 2031. People with COPD are at increased risk of developing heart disease, lung cancer and a variety of other conditions. According to the World Health Organization (WHO), COPD is the third leading cause of death globally. The demand for inhalation therapies is also increasing with the increase in the burden of respiratory diseases. Additionally, the shift in preference for home care treatments fuels the utilization of handheld nebulizers for the management of COPD and asthma.

Based on end- user, the nebulizers market is segmented into hospitals and clinics, emergency centers, and home care settings. The hospitals and clinics segment held the largest share of the market in 2023 and is expected to register the highest CAGR from 2023 to 2030 owing to the medical availability of various types of nebulizers and the growing adoption rate of these devices in hospital settings.

Nebulizers Market: Geographical Overview

The scope of the global nebulizers market report entails North America (the US, Canada, and Mexico), Europe (Germany, France, Italy, the UK, Spain, and the Rest of Europe), Asia Pacific (China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific), the Middle East & Africa (South Africa, Saudi Arabia, the UAE, and the Rest of Middle East & Africa), and South & Central America (Brazil, Argentina, and the Rest of South & Central America). North America held a major nebulizers market share in 2023, followed by Europe; the market in Asia Pacific region is growing with the highest CAGR during the forecast period. This is attributed to developing healthcare infrastructure in emerging markets, rising healthcare expenditure, lucrative reimbursement policies, and increasing emphasis on better patient outcomes in the region.

1. Introduction

1.1 Scope of the Study
1.2 Market Definition, Assumptions and Limitations
1.3 Market Segmentation

2. Executive Summary

2.1 Key Insights
2.2 Market Attractiveness Analysis

3. Research Methodology

4. Nebulizers Market Landscape

4.1 Overview
4.2 PEST Analysis
4.3 Ecosystem Analysis
- 4.3.1 List of Vendors in the Value Chain

5. Nebulizers Market - Key Market Dynamics

5.1 Key Market Drivers
5.2 Key Market Restraints
5.3 Key Market Opportunities
5.4 Future Trends
5.5 Impact Analysis of Drivers and Restraints

6. Nebulizers Market - Global Market Analysis

6.1 Nebulizers - Global Market Overview
6.2 Nebulizers - Global Market and Forecast to 2030

7. Nebulizers Market - Revenue Analysis (USD Million) - By Type, 2020-2030

7.1 Overview
7.2 Jet Nebulizers
7.3 Ultrasonic Nebulizers
7.4 Mesh Nebulizers

8. Nebulizers Market - Revenue Analysis (USD Million) - By Application , 2020-2030

8.1 Overview
8.2 COPD
8.3 Asthma
8.4 Cystic Fibrosis
8.5 Others

9. Nebulizers Market - Revenue Analysis (USD Million) - By End-User, 2020-2030

9.1 Overview
9.2 Hospitals and Clinics
9.3 Emergency Center
9.4 Home Care Setting

10. Nebulizers Market - Revenue Analysis (USD Million), 2020-2030 - Geographical Analysis

10.1 North America
- 10.1.1 North America Nebulizers Market Overview
- 10.1.2 North America Nebulizers Market Revenue and Forecasts to 2030
- 10.1.3 North America Nebulizers Market Revenue and Forecasts and Analysis - By Type
- 10.1.4 North America Nebulizers Market Revenue and Forecasts and Analysis - By Application
- 10.1.5 North America Nebulizers Market Revenue and Forecasts and Analysis - By End-User
- 10.1.6 North America Nebulizers Market Revenue and Forecasts and Analysis - By Countries
  - 10.1.6.1 United States Nebulizers Market
    - 10.1.6.1.1 United States Nebulizers Market, by Type
    - 10.1.6.1.2 United States Nebulizers Market, by Application
    - 10.1.6.1.3 United States Nebulizers Market, by End-User
  - 10.1.6.2 Canada Nebulizers Market
    - 10.1.6.2.1 Canada Nebulizers Market, by Type
    - 10.1.6.2.2 Canada Nebulizers Market, by Application
    - 10.1.6.2.3 Canada Nebulizers Market, by End-User
  - 10.1.6.3 Mexico Nebulizers Market
    - 10.1.6.3.1 Mexico Nebulizers Market, by Type
    - 10.1.6.3.2 Mexico Nebulizers Market, by Application
    - 10.1.6.3.3 Mexico Nebulizers Market, by End-User

Note - Similar analysis would be provided for below mentioned regions/countries

10.2 Europe
- 10.2.1 Germany
- 10.2.2 France
- 10.2.3 Italy
- 10.2.4 Spain
- 10.2.5 United Kingdom
- 10.2.6 Rest of Europe
10.3 Asia-Pacific
- 10.3.1 Australia
- 10.3.2 China
- 10.3.3 India
- 10.3.4 Japan
- 10.3.5 South Korea
- 10.3.6 Rest of Asia-Pacific
10.4 Middle East and Africa
- 10.4.1 South Africa
- 10.4.2 Saudi Arabia
- 10.4.3 U.A.E
- 10.4.4 Rest of Middle East and Africa
10.5 South and Central America
- 10.5.1 Brazil
- 10.5.2 Argentina
- 10.5.3 Rest of South and Central America

11. Industry Landscape

11.1 Mergers and Acquisitions
11.2 Agreements, Collaborations, Joint Ventures
11.3 New Product Launches
11.4 Expansions and Other Strategic Developments

12. Competitive Landscape

12.1 Heat Map Analysis by Key Players
12.2 Company Positioning and Concentration

13. Nebulizers Market - Key Company Profiles

13.1 GE Healthcare
- 13.1.1 Key Facts
- 13.1.2 Business Description
- 13.1.3 Products and Services
- 13.1.4 Financial Overview
- 13.1.5 SWOT Analysis
- 13.1.6 Key Developments

Note - Similar information would be provided for below list of companies